Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Multi-centre, Open-label, Extension Study to Investigate the Long-term Safety of SPD422 in Japanese Adults With Essential Thrombocythaemia

NCT01467661 is registered in ClinicalTrials.gov with Shire as lead sponsor.

NCT NCT01467661
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01467661 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Multi-centre, Open-label, Extension Study to Investigate the Long-term Safety of SPD422 in Japanese Adults With Essential Thrombocythaemia
Lead sponsor
Shire
Phase
Phase 3
Overall status
Completed
Start date
October 27, 2010
Completion date
May 1, 2015
Enrollment
41 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

essential thrombocythemia (et)